ArticleOncoimmunology2023

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression.

Paul G Pavicic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.